Curis
CRIS
#11081
Rank
C$0.94 M
Marketcap
C$0.49
Share price
-17.89%
Change (1 day)
-78.38%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2026 (TTM): -C$9.59 Million

According to Curis's latest financial reports the company's current earnings are C$7.06 Million. In 2025 the company made an earning of -C$7.57 Million, an increase over its 2024 earnings that were of -C$59.96 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$9.59 Million26.65%
2025 -C$7.57 Million-87.38%
2024 -C$59.96 Million-5.77%
2023 -C$63.63 Million-13.1%
2022 -C$73.22 Million27.52%
2021 -C$57.42 Million65.09%
2020 -C$34.79 Million-9.1%
2019 -C$38.27 Million-4.73%
2018 -C$40.16 Million-41.95%
2017 -C$69.18 Million-14.37%
2016 -C$80.79 Million3.55%
2015 -C$78.02 Million271.52%
2014 -C$21 Million76.64%
2013 -C$11.89 Million
2011 -C$10.1 Million27.76%
2010 -C$7.91 Million-43.87%
2009 -C$14.08 Million-23.44%
2008 -C$18.39 Million56.66%
2007 -C$11.74 Million-16.71%
2006 -C$14.1 Million-36.92%
2005 -C$22.35 Million156.25%
2004 -C$8.72 Million-37.24%
2003 -C$13.9 Million-93.34%
2002 -C$0.21 Billion86.79%
2001 -C$0.12 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
C$14.84 B-156,794.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$13.45 B-142,088.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-C$86.74 Million 815.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
C$1.40 B-14,942.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-C$0.44 Billion 4,472.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-C$31.12 Million 228.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$82.84 M-974.39%๐Ÿ‡บ๐Ÿ‡ธ USA